Items where authors include "Newell-Price, J."

Article

Arshad, M.F. orcid.org/0000-0001-9932-0941, Elder, C. orcid.org/0000-0003-2390-5593, Newell-Price, J. orcid.org/0000-0002-0835-5493 et al. (2 more authors) (2024) A retrospective study on weaning glucocorticoids and recovery of the hypothalamic-pituitary-adrenal axis. The Journal of Clinical Endocrinology & Metabolism. ISSN 0021-972X

Lawrence, N.R. orcid.org/0000-0002-7560-0268, Arshad, M.F. orcid.org/0000-0001-9932-0941, Pofi, R. orcid.org/0000-0001-7808-5735 et al. (7 more authors) (2023) Multivariable model to predict an ACTH stimulation test to diagnose adrenal insufficiency using previous test results. Journal of the Endocrine Society, 7 (12). bvad127. ISSN 2472-1972

Newell-Price, J. (2023) Testing for arginine vasopressin deficiency. New England Journal of Medicine, 389 (20). pp. 1920-1921. ISSN 0028-4793

Cozzolino, A., Hasenmajer, V., Newell-Price, J. et al. (1 more author) (2023) COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders. Endocrine, 82. pp. 1-14. ISSN 1355-008X

Pelsma, I.C.M. orcid.org/0000-0003-4956-4037, Fassnacht, M. orcid.org/0000-0001-6170-6398, Tsagarakis, S. orcid.org/0000-0003-1959-8738 et al. (9 more authors) (2023) Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis. European Journal of Endocrinology, 189 (4). S88-S101. ISSN 0804-4643

Fassnacht, M. orcid.org/0000-0001-6170-6398, Tsagarakis, S., Terzolo, M. orcid.org/0000-0002-4171-2851 et al. (9 more authors) (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. European Journal of Endocrinology, 189 (1). G1-G42. ISSN 0804-4643

Hamblin, R., Fountas, A., Lithgow, K. et al. (49 more authors) (2023) Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium. European Journal of Endocrinology, 189 (1). pp. 87-95. ISSN 0804-4643

Debono, M. orcid.org/0000-0002-1059-9702, Elder, C.J. orcid.org/0000-0003-2390-5593, Lewis, J. et al. (8 more authors) (2023) Home waking salivary cortisone to screen for adrenal insufficiency. NEJM Evidence, 2 (2). ISSN 2766-5526

Arima, H., Cheetham, T., Christ-Crain, M. et al. (8 more authors) (2022) Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus. Endocrine Connections, 11 (11). e220378. ISSN 2049-3614

Atila, C., Loughrey, P.B., Garrahy, A. et al. (15 more authors) (2022) Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. Lancet Diabetes and Endocrinology, 10 (10). pp. 700-709. ISSN 2213-8587

Kelsall, A. and Newell-Price, J. orcid.org/0000-0002-0835-5493 (2022) Cushing mortality in remission: not out of the woods. The Journal of Clinical Endocrinology & Metabolism, 107 (10). e4232-e4233. ISSN 0021-972X

Fleseriu, M., Newell-Price, J., Pivonello, R. et al. (12 more authors) (2022) Long-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension. European Journal of Endocrinology, 187 (4). pp. 531-541. ISSN 0804-4643

Newey, P.J. and Newell-Price, J. (2022) MEN1 surveillance guidelines : time to (re)think? Journal of the Endocrine Society, 6 (2). pp. 1-5.

Ramezanipour, N., Esfahani, S.H.Z., Eastell, R. orcid.org/0000-0002-0323-3366 et al. (4 more authors) (2022) Development of a hypoparathyroid male rodent model for testing delayed-clearance PTH molecules. Endocrinology, 163 (2). bqab239. ISSN 0013-7227

Newell-Price, J., Huatan, H., Quirke, J. et al. (7 more authors) (2021) An oral lipidic native testosterone formulation that is absorbed independent of food. European Journal of Endocrinology, 185 (5). pp. 607-615. ISSN 0804-4643

Sims-Williams, H.P., Rajapaksa, K., Yianni, J. et al. (6 more authors) (2021) Long-term safety of gamma knife radiosurgery (SRS) for acromegaly. Pituitary, 24 (5). pp. 724-736. ISSN 1386-341X

Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2021) Modified-release hydrocortisone in congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism, 106 (5). e2063-e2077. ISSN 0021-972X

Pivonello, R., Fleseriu, M., Newell-Price, J. et al. (14 more authors) (2020) Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3) : a multicentre phase III study with a doubleblind, randomised withdrawal phase. The Lancet Diabetes & Endocrinology, 8 (9). pp. 748-761. ISSN 2213-8587

Newell-Price, J., Nieman, L.K., Reincke, M. et al. (1 more author) (2020) Endocrinology in the time of COVID-19: Management of Cushing’s syndrome. European Journal of Endocrinology, 183 (1). G1-G7. ISSN 0804-4643

Newell-Price, J., Pivonello, R., Tabarin, A. et al. (9 more authors) (2020) Use of late-night salivary cortisol to monitor response to medical treatment in Cushing’s disease. European Journal of Endocrinology, 182 (2). pp. 207-217. ISSN 0804-4643

Harrison, R.F., Debono, M., Whitaker, M.J. et al. (3 more authors) (2018) Salivary cortisone to estimate cortisol exposure and sampling frequency required based on serum cortisol measurements. Journal of Clinical Endocrinology and Metabolism. ISSN 0021-972X

Daniel, E. orcid.org/0000-0003-4699-420X, Debono, M., Caunt, S. et al. (6 more authors) (2018) A prospective longitudinal study of Pasireotide in Nelson's syndrome. Pituitary, 21. pp. 247-255. ISSN 1386-341X

Lacroix, A., Gu, F., Gallardo, W. et al. (12 more authors) (2018) Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial. The Lancet Diabetes and Endocrinology, 6 (1). pp. 17-26. ISSN 2213-8587

Debono, M., Harrison, R.F., Chadarevian, R. et al. (3 more authors) (2017) Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion. Journal of Clinical Endocrinology and Metabolism, 102 (9). pp. 3461-3469. ISSN 0021-972X

Daniel, E. orcid.org/0000-0003-4699-420X and Newell-Price, J. (2017) Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations. F1000Research, 6. p. 613. ISSN 2046-1402

Daniel, E. orcid.org/0000-0003-4699-420X, Jones, R., Bull, M. et al. (1 more author) (2016) Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase (SDHx) mutations. European Journal of Endocrinology , 175. pp. 561-570. ISSN 0804-4643

Speak, R., Cook, J., Harrison, B. et al. (1 more author) (2016) Disease-modifying polymorphisms and C609Y mutation of RET associated with high penetrance of phaeochromocytoma and low rate of MTC in MEN2A. Endocrinology, Diabetes and Metabolism Case Reports, 2016. EDM160093. ISSN 2052-0573

Jones, R., McDonald, K.E., Willson, J.A. et al. (15 more authors) (2016) Mutations in succinate dehydrogenase B (SDHB) enhance neutrophil survival independent of HIF-1α expression. Blood, 127 (21). pp. 2641-2644. ISSN 0006-4971

Findling, J.W., Fleseriu, M., Newell-Price, J. et al. (5 more authors) (2016) Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study. Endocrine, 54 (2). pp. 516-523. ISSN 1355-008X

Daniel, E. orcid.org/0000-0003-4699-420X, Aylwin, S., Mustafa, O. et al. (25 more authors) (2015) Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 100 (11). pp. 4146-4154. ISSN 0021-972X

Wolin, E.M., Jarzab, B., Eriksson, B. et al. (16 more authors) (2015) Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues. Drug Design, Development and Therapy, 9. pp. 5075-5086. ISSN 1177-8881

Petersenn, S., Newell-Price, J., Findling, J. W. et al. (7 more authors) (2014) High variability in baseline urinary free cortisol values in patients with Cushing's disease. Clinical Endocrinology, 80 (2). pp. 261-269. ISSN 0300-0664

Debono, M., Chadarevian, R., Eastell, R. orcid.org/0000-0002-0323-3366 et al. (2 more authors) (2013) Mifepristone Reduces Insulin Resistance in Patient Volunteers with Adrenal Incidentalomas That Secrete Low Levels of Cortisol: A Pilot Study. PLOS ONE, 8 (4). ARTN e60984. ISSN 1932-6203

Debono, M., Ghobadi, C., Rostami-Hodjegan, A. et al. (7 more authors) (2009) Modified-release hydrocortisone to provide circadian cortisol profiles. Journal of Clinical Endocrinology and Metabolism, 94 (5). pp. 1548-1554. ISSN 0021-972X

Bevan, J. S., Newell-Price, J., Wass, J. A. H. et al. (8 more authors) (2008) Home administration of lanreotide Autogel (R) by patients with acromegaly, or their partners, is safe and effective. Clinical Endocrinology, 68 (3). pp. 343-349. ISSN 0300-0664

Conference or Workshop Item

Liyanarachchi, K., Amarawardena, M., Newell-Price, J. et al. (2 more authors) (2017) Pasireotide: successful treatment of a resistant case of Acromegaly. In: Society for Endocrinology Endocrine Update 2017.

Proceedings Paper

Debono, M., Elder, C. orcid.org/0000-0003-2390-5593, Lewis, J. et al. (7 more authors) (2022) Waking salivary cortisone as screening test for adrenal insufficiency. In: Endocrine Abstracts. 24th European Congress of Endocrinology - ECE 2022, 21-24 May 2022, Milan, Italy. Endocrine Abstracts, 81 . Bioscientifica .